Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Serial Ultrasound for Kidney Cancer
Recruiting1 award6 criteria
Stanford, California
This trial will look at whether changes in how blood flows through tumors after 3 weeks of treatment can predict whether the treatment is working at 12 weeks.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.